Gossamer Bio (GOSS) Change in Cash (2018 - 2026)
Gossamer Bio (GOSS) posted quarterly Change in Cash of $3.3 million for Q1 2026, up 119.33% year-over-year from $1.5 million in Q1 2025, and down 88.56% quarter-over-quarter from $28.8 million in Q4 2025.
Gossamer Bio (GOSS) Change in Cash (2018 - 2026) Analysis & Trends
Gossamer Bio's Change in Cash history runs 9 years deep, the most recent figure standing at $3.3 million for Q1 2026.
- In Q1 2026, Change in Cash rose 119.33% year-over-year to $3.3 million; the TTM figure through Mar 2026 stood at $12.0 million (up 222.0% YoY), while the FY2025 annual figure was -$8.3 million, down 159.74% from the prior year.
- Change in Cash for Q1 2026 stood at $3.3 million, down from $28.8 million in the prior quarter.
- The five-year high for Change in Cash was $59.2 million in Q3 2022, with the low at -$58.4 million in Q3 2024.
- The 5-year median for Change in Cash is -$17.1 million (2025), against an average of -$8.4 million.
- The sharpest annual moves came in 2024 and 2025: Change in Cash surged 270.03% in 2024, then slumped 352.49% in 2025.
- Gossamer Bio's Change in Cash stood at -$41.5 million in 2022, then declined by 21.68% to -$50.5 million in 2023, then soared by 134.87% to $17.6 million in 2024, then jumped by 63.54% to $28.8 million in 2025, then sank by 88.56% to $3.3 million in 2026.
- Business Quant data shows GOSS's Change in Cash at $3.3 million in Q1 2026, $28.8 million in Q4 2025, and -$17.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Gossamer Bio | 49.15 Mn | -7.87 Mn | - | 120,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 120,000.00 |
| Mar 31, 2026 | 3.30 Mn |
| Dec 31, 2025 | 28.80 Mn |
| Sep 30, 2025 | -17.38 Mn |
| Jun 30, 2025 | -2.71 Mn |
| Mar 31, 2025 | -17.05 Mn |
| Dec 31, 2024 | 17.61 Mn |
| Sep 30, 2024 | -58.41 Mn |
| Jun 30, 2024 | 48.01 Mn |
| Mar 31, 2024 | 6.75 Mn |
| Dec 31, 2023 | -50.50 Mn |
| Sep 30, 2023 | 45.61 Mn |
| Jun 30, 2023 | -28.24 Mn |
| Mar 31, 2023 | -46.73 Mn |
| Dec 31, 2022 | -41.50 Mn |
| Sep 30, 2022 | 59.16 Mn |
| Jun 30, 2022 | -44.66 Mn |
| Mar 31, 2022 | -44.50 Mn |
| Dec 31, 2021 | -30.07 Mn |
| Sep 30, 2021 | -129.48 Mn |